Cochrane Pain, Palliative and Supportive Care, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Mental Health and Neuroscience Network and Acute and Emergency Care Network, Cochrane, London, UK.
Cochrane Database Syst Rev. 2021 May 24;5(5):CD013544. doi: 10.1002/14651858.CD013544.pub2.
The World Health Organization (WHO) recommends that people of all ages take regular and adequate physical activity. If unable to meet the recommendations due to health conditions, international guidance advises being as physically active as possible. Evidence from community interventions of physical activity indicate that people living with medical conditions are sometimes excluded from participation in studies. In this review, we considered the effects of activity-promoting interventions on physical activity and well-being in studies, as well as any adverse events experienced by participants living with inherited or acquired neuromuscular diseases (NMDs). OBJECTIVES: To assess the effects of interventions designed to promote physical activity in people with NMD compared with no intervention or alternative interventions.
On 30 April 2020, we searched Cochrane Neuromuscular Specialised Register, CENTRAL, Embase, MEDLINE, and ClinicalTrials.Gov. WHO ICTRP was not accessible at the time.
We considered randomised or quasi-randomised trials, including cross-over trials, of interventions designed to promote physical activity in people with NMD compared to no intervention or alternative interventions. We specifically included studies that reported physical activity as an outcome measure. Our main focus was studies in which promoting physical activity was a stated aim but we also included studies in which physical activity was assessed as a secondary or exploratory outcome.
We used standard Cochrane procedures.
The review included 13 studies (795 randomised participants from 12 studies; number of participants unclear in one study) of different interventions to promote physical activity. Most studies randomised a minority of invited participants. No study involved children or adolescents and nine studies reported minimal entry criteria for walking. Participants had one of nine inherited or acquired NMDs. Types of intervention included structured physical activity support, exercise support (as a specific form of physical activity), and behaviour change support that included physical activity or exercise. Only one included study clearly reported that the aim of intervention was to increase physical activity. Other studies reported or planned to analyse the effects of intervention on physical activity as a secondary or exploratory outcome measure. Six studies did not report results for physical activity outcomes, or the data were not usable. We judged 10 of the 13 included studies at high or unclear risk of bias from incomplete physical activity outcome reporting. We did not perform a meta-analysis for any comparison because of differences in interventions and in usual care. We also found considerable variation in how studies reported physical activity as an outcome measure. The studies that reported physical activity measurement did not always clearly report intention-to-treat (ITT) analysis or whether final assessments occurred during or after intervention. Based on prespecified measures, we included three comparisons in our summary of findings. A physical activity programme (weight-bearing) compared to no physical activity programme One study involved adults with diabetic peripheral neuropathy (DPN) and reported weekly duration of walking during and at the end of a one-year intervention using a StepWatch ankle accelerometer. Based on the point estimate and low-certainty evidence, intervention may have led to an important increase in physical activity per week; however, the 95% confidence interval (CI) included the possibility of no difference or an effect in either direction at three months (mean difference (MD) 34 minutes per week, 95% CI -92.19 to 160.19; 69 participants), six months (MD 68 minutes per week, 95% CI -55.35 to 191.35; 74 participants), and 12 months (MD 49 minutes per week, 95% CI -75.73 to 173.73; 70 participants). Study-reported effect estimates for foot lesions and full-thickness ulcers also included the possibility of no difference, a higher, or lower risk with intervention. A sensor-based, interactive exercise programme compared to no sensor-based, interactive exercise programme One study involved adults with DPN and reported duration of walking over 48 hours at the end of four weeks' intervention using a t-shirt embedded PAMSys sensor. It was not possible to draw conclusions about the effectiveness of the intervention from the very low-certainty evidence (MD -0.64 hours per 48 hours, 95% CI -2.42 to 1.13; 25 participants). We were also unable to draw conclusions about impact on the Physical Component Score (PCS) for quality of life (MD 0.24 points, 95% CI -5.98 to 6.46; 35 participants; very low-certainty evidence), although intervention may have made little or no difference to the Mental Component Score (MCS) for quality of life (MD 5.10 points, 95% CI -0.58 to 10.78; 35 participants; low-certainty evidence). A functional exercise programme compared to a stretching exercise programme One study involved adults with spinal and bulbar muscular atrophy and reported a daily physical activity count at the end of 12 weeks' intervention using an Actical accelerometer. It was not possible to draw conclusions about the effectiveness of either intervention (requiring compliance) due to low-certainty evidence and unconfirmed measurement units (MD -8701, 95% CI -38,293.30 to 20,891.30; 43 participants). Functional exercise may have made little or no difference to quality of life compared to stretching (PCS: MD -1.10 points, 95% CI -5.22 to 3.02; MCS: MD -1.10 points, 95% CI -6.79 to 4.59; 49 participants; low-certainty evidence). Although studies reported adverse events incompletely, we found no evidence of supported activity increasing the risk of serious adverse events.
AUTHORS' CONCLUSIONS: We found a lack of evidence relating to children, adolescents, and non-ambulant people of any age. Many people living with NMD did not meet randomised controlled trial eligibility criteria. There was variation in the components of supported activity intervention and usual care, such as physical therapy provision. We identified variation among studies in how physical activity was monitored, analysed, and reported. We remain uncertain of the effectiveness of promotional intervention for physical activity and its impact on quality of life and adverse events. More information is needed on the ITT population, as well as more complete reporting of outcomes. While there may be no single objective measure of physical activity, the study of qualitative and dichotomous change in self-reported overall physical activity might offer a pragmatic approach to capturing important change at an individual and population level.
世界卫生组织(WHO)建议所有年龄段的人定期进行充足的身体活动。如果由于健康状况而无法满足建议,国际指南建议尽可能进行身体活动。社区身体活动干预的证据表明,患有医疗条件的人有时会被排除在研究之外。在本综述中,我们考虑了促进活动的干预措施对患有遗传性或获得性神经肌肉疾病(NMD)的参与者的身体活动和幸福感的影响,以及参与者经历的任何不良事件。
评估与无干预或替代干预相比,旨在促进 NMD 患者身体活动的干预措施的效果。
2020 年 4 月 30 日,我们在 Cochrane 神经肌肉专业注册库、CENTRAL、Embase、MEDLINE 和 ClinicalTrials.gov 上进行了检索。当时无法访问世卫组织国际临床试验注册平台。
我们考虑了随机或准随机试验,包括交叉试验,这些试验比较了旨在促进 NMD 患者身体活动的干预措施与无干预或替代干预措施。我们特别纳入了将身体活动作为衡量指标的研究。我们的主要重点是将促进身体活动作为既定目标的研究,但我们也纳入了将身体活动作为次要或探索性结果进行评估的研究。
我们使用了标准的 Cochrane 程序。
综述纳入了 13 项研究(12 项研究中的 795 名随机参与者;一项研究的参与者人数不清楚),这些研究采用了不同的干预措施来促进身体活动。大多数研究仅随机选择了少数受邀参与者。没有研究涉及儿童或青少年,九项研究报告了行走的最低进入标准。参与者患有九种遗传性或获得性 NMD 之一。干预措施包括结构化的身体活动支持、运动支持(作为一种特定形式的身体活动)和包括身体活动或运动的行为改变支持。只有一项纳入的研究明确报告干预的目的是增加身体活动。其他研究报告或计划分析干预对身体活动的影响作为次要或探索性结果测量。六项研究未报告身体活动结果数据,或数据不可用。我们判断 13 项纳入研究中的 10 项由于身体活动结果报告不完整而存在高或不确定的偏倚风险。由于干预措施和常规护理的差异,我们没有对任何比较进行荟萃分析。我们还发现,研究报告身体活动结果的方式存在很大差异。报告身体活动测量的研究并不总是明确报告意向治疗(ITT)分析或最终评估是否在干预期间或之后进行。根据预先指定的措施,我们在总结发现中包括了三项比较。一项身体活动计划(负重)与无身体活动计划一项研究涉及患有糖尿病周围神经病变(DPN)的成年人,使用 StepWatch 脚踝加速度计报告了为期一年干预期间和结束时每周的步行时长。基于点估计值和低确定性证据,干预可能导致每周身体活动量显著增加;然而,95%置信区间(CI)包括三个月时无差异或任何方向效果的可能性(平均差异(MD)34 分钟/周,95%CI -92.19 至 160.19;69 名参与者)、六个月(MD 68 分钟/周,95%CI -55.35 至 191.35;74 名参与者)和 12 个月(MD 49 分钟/周,95%CI -75.73 至 173.73;70 名参与者)。研究报告的足部病变和全厚度溃疡的效应估计值也包括干预后风险增加、不变或降低的可能性。一项基于传感器的互动运动计划与无基于传感器的互动运动计划一项研究涉及患有 DPN 的成年人,使用嵌入 t 恤的 PAMSys 传感器报告了四周干预结束时 48 小时的步行时长。由于极低确定性证据,无法从研究中得出干预效果的结论(MD -0.64 小时/48 小时,95%CI -2.42 至 1.13;25 名参与者)。我们也无法得出关于生活质量的物理成分评分(PCS)影响的结论(MD 0.24 分,95%CI -5.98 至 6.46;35 名参与者;极低确定性证据),尽管干预可能对生活质量的心理成分评分(MCS)几乎没有或没有影响(MD 5.10 分,95%CI -0.58 至 10.78;35 名参与者;低确定性证据)。一项功能性运动计划与拉伸运动计划一项研究涉及患有脊髓和延髓肌肉萎缩症的成年人,使用 Actical 加速度计报告了 12 周干预结束时的每日身体活动计数。由于低确定性证据和未经证实的测量单位,我们无法得出任何一种干预措施(需要依从性)有效的结论(MD -8701,95%CI -38,293.30 至 20,891.30;43 名参与者)。与拉伸运动相比,功能性运动对生活质量的影响可能较小或没有差异(PCS:MD -1.10 分,95%CI -5.22 至 3.02;MCS:MD -1.10 分,95%CI -6.79 至 4.59;49 名参与者;低确定性证据)。尽管研究报告不良事件不完整,但我们没有发现支持活动增加严重不良事件风险的证据。
我们发现缺乏关于儿童、青少年和任何年龄段非活动人群的证据。许多患有 NMD 的人不符合随机对照试验的纳入标准。支持活动干预和常规护理的组成部分存在差异,例如提供物理治疗。我们发现研究之间在监测、分析和报告身体活动方面存在差异。我们仍然不确定促进身体活动的干预措施对身体活动和生活质量以及不良事件的有效性。需要更多关于 ITT 人群的信息,以及更完整的结果报告。虽然可能没有单一的身体活动客观衡量标准,但研究自我报告的整体身体活动的定性和二分变化可能提供一种实用方法,可在个体和人群层面捕捉重要变化。